DCM
TMO icon

Davidson Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Davidson Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,871
Closed -$3.05M – 91
2024
Q4 		$3.05M Buy
5,871
+305
+5% +$168K 0.8% 41
2024
Q3 		$3.44M Buy
5,566
+295
+6% +$175K 0.99% 18
2024
Q2 		$2.91M Buy
5,271
+522
+11% +$299K 0.9% 44
2024
Q1 		$2.76M Buy
4,749
+15
+0.3% +$8.42K 0.89% 28
2023
Q4 		$2.51M Buy
4,734
+2,162
+84% +$1.05M 0.91% 25
2023
Q3 		$1.3M Sell
2,572
-6
-0.2% -$3.2K 0.65% 41
2023
Q2 		$1.35M Buy
2,578
+44
+2% +$23.7K 0.67% 47
2023
Q1 		$1.46M Buy
2,534
+143
+6% +$80.6K 0.89% 23
2022
Q4 		$1.32M Sell
2,391
-21
-0.9% -$11.1K 0.9% 19
2022
Q3 		$1.22M Buy
2,412
+102
+4% +$57.1K 0.6% 23
2022
Q2 		$1.25M Hold
2,310
– – 0.59% 18
2022
Q1 		$1.36M Sell
2,310
-192
-8% -$110K 0.51% 31
2021
Q4 		$1.67M Buy
2,502
+64
+3% +$40K 0.91% 14
2021
Q3 		$1.39M Sell
2,438
-252
-9% -$138K 0.7% 13
2021
Q2 		$1.36M Buy
2,690
+378
+16% +$178K 0.65% 21
2021
Q1 		$1.05M Buy
2,312
+400
+21% +$191K 0.55% 67
2020
Q4 		$891K Buy
1,912
+54
+3% +$25.3K 0.5% 44
2020
Q3 		$820K Buy
+1,858
New +$768K 0.52% 31

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Davidson Capital Management's TMO Position: Q1 2025 in Review

Davidson Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2025, closing a stake of 5,871 shares — an estimated $3.05M sold.

Davidson Capital Management first reported a position in TMO in Q3 2020 and held it in 18 quarters. The position peaked at $3.44M in Q3 2024. 2,571 funds tracked by Wall St. Rank hold TMO as of Q1 2025.

  • Davidson Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2025 after selling out during the quarter.
  • Davidson Capital Management sold 5,871 Thermo Fisher Scientific shares in Q1 2025, an estimated $3.05M.
  • Davidson Capital Management first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 18 quarters.
  • Davidson Capital Management's Thermo Fisher Scientific position peaked at $3.44M in Q3 2024.
  • 2,571 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2025.

Based on Davidson Capital Management's 13F filing for Q1 2025, filed 21 Apr 2025.